0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Human Health Effects Nanoplastics Policy & Risk Sign in to save

Micro- and Nanoplastics in the Brain: A Scoping Review Protocol on Their Presence, Neurotoxic Effects, and Implications for Human Health

Open Science Framework 2025 Score: 48 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Kayke Kauã de Siqueira, João Pedro Araújo Herculano, Geisa Maria de Sousa, Geisa Maria de Sousa, Fábio Antônio Mota Fonseca da Silva, Fábio Antônio Mota Fonseca da Silva

Summary

This scoping review protocol maps scientific evidence on the presence of micro- and nanoplastics in the brain, their neurotoxic effects, and implications for human health, drawing from both human studies and experimental models. The protocol follows JBI methodology to systematically chart available evidence.

Body Systems

This scoping review protocol aims to map the scientific evidence on the presence of micro- and nanoplastics in the brain, their neurotoxic effects, and potential implications for human health. Evidence from human studies and experimental models will be systematically charted following JBI methodology and PRISMA-ScR guidelines to identify key mechanisms, affected brain regions, and knowledge gaps.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Micro- and Nanoplastics in the Brain: A Scoping Review Protocol on Their Presence, Neurotoxic Effects, and Implications for Human Health

This scoping review protocol outlines a systematic approach to mapping scientific evidence on the presence of micro- and nanoplastics in the brain, their neurotoxic effects, and potential implications for human health. The review will chart findings from both human studies and experimental models to identify key mechanisms, affected brain regions, and knowledge gaps in this emerging field.

Article Tier 2

Insights into the toxic effects of micro-nano-plastics on the human brain and their relationship with the onset of neurological diseases: A narrative review.

This review examined toxic effects of micro and nano-plastics (MNPs) on the human brain, linking MNP exposure to neuroinflammation, oxidative stress, disruption of the blood-brain barrier, and progression toward neurodegenerative diseases. The authors synthesized evidence from cell studies, animal models, and emerging human data.

Systematic Review Tier 1

A systematic review of the potential neurotoxicity of micro-and nanoplastics: the known and unknown

This critical review of 234 studies found that micro- and nanoplastics can reach the brain via olfactory translocation or by crossing the blood-brain barrier, where they may cause neuroinflammation, oxidative damage, and behavioral changes in animal models. The evidence raises significant concerns about potential neurotoxic effects of chronic microplastic exposure in humans, though major knowledge gaps remain.

Article Tier 2

The plastic brain part II: new insights into micro- and nanoplastics neurotoxicity

This systematic review evaluated neurotoxicity evidence from studies on micro- and nanoplastic (MNP) exposure, covering a rapidly growing body of literature. The authors found consistent evidence of neuroinflammation, oxidative stress, and behavioral disruption across multiple model systems, though dose-response relationships and human relevance remain areas of uncertainty.

Article Tier 2

Micro-nanoplastics in the central nervous system: Evidence, mechanisms and perspectives

This review examines evidence that micro- and nanoplastics can cross the blood-brain barrier and cause neurotoxicity through oxidative stress, neuroinflammation, and disruption of neurotransmitter signaling. While clinical studies have confirmed the presence of plastic particles in human brain tissue and cerebrospinal fluid, the authors note that methodological limitations and inconsistent quality controls currently prevent establishing a definitive causal link to neurological conditions.

Share this paper